Organon to conduct multinational studies in patients with breast cancer

Published: 2003-03-10 06:56:00

Updated: 2003-03-10 06:56:00

In the large, multinational (25 countries), multicenter (150 hospitals) clinical trials, Organon intends to assess the effect and safety of Livial (tibolone) in patients with the history of breast cancer who have complained their climacteric symptoms and to enhance their quality of life. In Korea...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK